Safety of paranasal sinus surgery in patients with cystic fibrosis

Douglas L. Schulte, Jan Kasperbauer

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Objective: Document the safety of paranasal sinus surgery in cystic fibrosis patients and review the changing trends in paranasal sinus surgery in the cystic fibrosis population. Study Design: Retrospective review. Materials and Methods: Chart review of cystic fibrosis patients who underwent paranasal sinus surgery from 1955 to 1997. Results: Indications for surgery included chronic sinusitis, nasal obstruction, purulent rhinorrhea, head pain, and pyocele. Average duration of anesthesia was 2.1 hours. The complication rate from general anesthesia was zero. Excessive bleeding and significant hypoxia did not occur. Conclusions: Paranasal sinus surgery and general anesthesia can be safely performed in cystic fibrosis patients. The indications for paranasal sinus surgery are changing from symptomatic nasal obstruction to pre-lung transplantation care. Today, treatment has evolved to include placement of sinus catheters for direct topical instillation of antibiotics and consideration of maxillary and frontal sinus obliteration.

Original languageEnglish (US)
Pages (from-to)1813-1815
Number of pages3
JournalLaryngoscope
Volume108
Issue number12
DOIs
StatePublished - Jan 1 1998

Fingerprint

Paranasal Sinuses
Cystic Fibrosis
Safety
Nasal Obstruction
General Anesthesia
Frontal Sinus
Lung Transplantation
Maxillary Sinus
Sinusitis
Headache
Catheters
Anesthesia
Retrospective Studies
Hemorrhage
Anti-Bacterial Agents
Population

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Safety of paranasal sinus surgery in patients with cystic fibrosis. / Schulte, Douglas L.; Kasperbauer, Jan.

In: Laryngoscope, Vol. 108, No. 12, 01.01.1998, p. 1813-1815.

Research output: Contribution to journalArticle

Schulte, Douglas L. ; Kasperbauer, Jan. / Safety of paranasal sinus surgery in patients with cystic fibrosis. In: Laryngoscope. 1998 ; Vol. 108, No. 12. pp. 1813-1815.
@article{4f47db5bba1a458ab0d98d4ba7ab01ff,
title = "Safety of paranasal sinus surgery in patients with cystic fibrosis",
abstract = "Objective: Document the safety of paranasal sinus surgery in cystic fibrosis patients and review the changing trends in paranasal sinus surgery in the cystic fibrosis population. Study Design: Retrospective review. Materials and Methods: Chart review of cystic fibrosis patients who underwent paranasal sinus surgery from 1955 to 1997. Results: Indications for surgery included chronic sinusitis, nasal obstruction, purulent rhinorrhea, head pain, and pyocele. Average duration of anesthesia was 2.1 hours. The complication rate from general anesthesia was zero. Excessive bleeding and significant hypoxia did not occur. Conclusions: Paranasal sinus surgery and general anesthesia can be safely performed in cystic fibrosis patients. The indications for paranasal sinus surgery are changing from symptomatic nasal obstruction to pre-lung transplantation care. Today, treatment has evolved to include placement of sinus catheters for direct topical instillation of antibiotics and consideration of maxillary and frontal sinus obliteration.",
author = "Schulte, {Douglas L.} and Jan Kasperbauer",
year = "1998",
month = "1",
day = "1",
doi = "10.1097/00005537-199812000-00009",
language = "English (US)",
volume = "108",
pages = "1813--1815",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Safety of paranasal sinus surgery in patients with cystic fibrosis

AU - Schulte, Douglas L.

AU - Kasperbauer, Jan

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Objective: Document the safety of paranasal sinus surgery in cystic fibrosis patients and review the changing trends in paranasal sinus surgery in the cystic fibrosis population. Study Design: Retrospective review. Materials and Methods: Chart review of cystic fibrosis patients who underwent paranasal sinus surgery from 1955 to 1997. Results: Indications for surgery included chronic sinusitis, nasal obstruction, purulent rhinorrhea, head pain, and pyocele. Average duration of anesthesia was 2.1 hours. The complication rate from general anesthesia was zero. Excessive bleeding and significant hypoxia did not occur. Conclusions: Paranasal sinus surgery and general anesthesia can be safely performed in cystic fibrosis patients. The indications for paranasal sinus surgery are changing from symptomatic nasal obstruction to pre-lung transplantation care. Today, treatment has evolved to include placement of sinus catheters for direct topical instillation of antibiotics and consideration of maxillary and frontal sinus obliteration.

AB - Objective: Document the safety of paranasal sinus surgery in cystic fibrosis patients and review the changing trends in paranasal sinus surgery in the cystic fibrosis population. Study Design: Retrospective review. Materials and Methods: Chart review of cystic fibrosis patients who underwent paranasal sinus surgery from 1955 to 1997. Results: Indications for surgery included chronic sinusitis, nasal obstruction, purulent rhinorrhea, head pain, and pyocele. Average duration of anesthesia was 2.1 hours. The complication rate from general anesthesia was zero. Excessive bleeding and significant hypoxia did not occur. Conclusions: Paranasal sinus surgery and general anesthesia can be safely performed in cystic fibrosis patients. The indications for paranasal sinus surgery are changing from symptomatic nasal obstruction to pre-lung transplantation care. Today, treatment has evolved to include placement of sinus catheters for direct topical instillation of antibiotics and consideration of maxillary and frontal sinus obliteration.

UR - http://www.scopus.com/inward/record.url?scp=0031774543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031774543&partnerID=8YFLogxK

U2 - 10.1097/00005537-199812000-00009

DO - 10.1097/00005537-199812000-00009

M3 - Article

VL - 108

SP - 1813

EP - 1815

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 12

ER -